We aimed to investigate polymyxin B (PMB) resistance and its molecular mechanisms 28 in 126 Klebsiella pneumoniae isolates from rectal swabs in Brazil. Ten isolates exhibited PMB 29 resistance with interruption of mgrB gene by insertion sequences or missense mutations. Most 30 of PMB resistant isolates harbored bla KPC-2 (N=8) and belonged to CC258 (N=7). These results 31 highlight the importance of monitoring the spread of polymyxin resistant bacteria in hospitals, 32 since few options remain to treat multidrug-resistant isolates. ????????????????????????????????????????????????????????????????????????????? (12), thus, the use of a dilution method to confirm the PMB susceptibility 82 is recommended (13). 83
Polymyxin has been widely used to treat infections caused by multidrug-resistant 52 (MDR) Gram-negative bacteria, including Klebsiella pneumoniae. However, reports of 53 polymyxin resistant K. pneumoniae (PRKP) have increased worldwide, becoming a great public 54 health concern (1). 55
Most studies on PRKP have focused on patients with infections. However, there have 56 been few reports assessing data of PRKP carriage in patients around the world (2). Some 57 studies have described a remarkable and concerning number of patients who developed 58 infection by PRKP after previous colonization resulting in elevated mortality rates (3, 4) . 59
Colonization by KPC-producing K. pneumoniae and polymyxin therapy are considered 60 important risk factors for PRKP infection (5, 6) . 61
Studies have demonstrated that modifications on PmrA/PmrB and PhoP/PhoQ two-62 component systems and inactivation of the mgrB gene (a regulator of PhoP/PhoQ system) 63 leads to polymyxin resistance by modification of the lipopolysaccharide target (7). Recently, 64 the plasmid-mediated transferable polymyxin resistance mcr-1 gene was identified in 65
Escherichia coli and K. pneumoniae causing resistance by modification of lipid A in China (8). 66
Here, we searched for molecular mechanisms associated with polymyxin resistance in 67 K. pneumoniae isolates from Brazil. A first-step screening for polymyxin B (PMB) resistance was 68 conducted using Etest (Biomérieux, France) (12), thus, the use of a dilution method to confirm the PMB susceptibility 82 is recommended (13). 83
The MIC for meropenem, imipenem and tigecycline were also determined by Etest and 84 the susceptibility to other antimicrobial agents was determined by agar diffusion (Table 1) . 85
Most of the isolates were non-susceptible to β-lactams (N=10), ciprofloxacin (N=9), 86 sulfamethoxazole/trimethoprim (N=9), gentamicin (N=7), chloramphenicol (N=7) and amikacin 87 (N=6); and remained susceptible to fosfomycin/trometamol (N=7) and tigecycline (N=7). Data 88 from SENTRY (2008) (2009) (2010) showed 3.2% of PRKP isolates in Brazil (14) . This rate increased to 89 6.6% in ESBL producing K. pneumoniae from medical centers in Latin America in 2011 (15) between PMB resistance and other acquired resistance mechanisms. 92
We performed PCR to detect resistance genes to β-lactams, quinolones and 93 aminoglycosides and sequencing when required. Genetic determinants associated with 94 resistance to those classes were observed in all isolates (Table 1) , being bla KPC-2 observed in 95 eight strains. The PFGE (17) and MLST (18) Regarding polymyxin resistance, the presence of mcr-1 gene was not detected. All the 111 ten PRKP strains exhibited alterations in mgrB gene (Table 1) , including disruption by IS903B, 112 IS5, IS102, ISKpn26 (IS5 family) and IS10L (IS4 family). Previous studies (2, 22, 23, 24) have 113 already shown the interruption of the mgrB region by IS10-like and IS5-like elements. This 114 mechanism seems to be common in K. pneumoniae, including KPC-producing isolates of CC258 115 (22). In Brazil, disruption of mgrB by IS903 was already reported in a BKC-1 (Brazilian Klebsiella 116 carbapenemase-1)-producing K. pneumoniae isolate from São Paulo (25). In addition, 117 deleterious mutations were observed in mgrB (C28R and Q30stop). Mutations on these same 118 amino acid positions were also reported in PRKP isolates from Europe (2, 22, 26) . 119
Alterations in phoQ gene were not detected. However, a partial deletion of PmrB 120 encoding gene was identified in one isolate and a deleterious mutation (R256G) was found in 121 70% of the isolates (Table 1 ). This specific mutation was not related to polymyxin resistance as 122 previously reported (27). The mutations T246A, E57G and A30S detected in PmrB, PmrA and 123 PhoP, respectively, were not considered deleterious by PROVEAN. Furthermore, we suggest 124 the PmrB (T246A) and PmrA (E57G) specific mutations found in this study were not capable to 125 produce PMB resistance alone, since these mutations were also found in PMB susceptible 126 isolates (data not shown). 127
In this study, the disruption of the mgrB was associated with PMB resistance in K. ????????????????????????????????????????????????????????????????????????????? 
